Edition:
United States

Aspen Technology Inc (AZPN.OQ)

AZPN.OQ on NASDAQ Stock Exchange Global Select Market

77.92USD
10:27am EST
Change (% chg)

$-0.10 (-0.13%)
Prev Close
$78.02
Open
$78.42
Day's High
$78.57
Day's Low
$77.88
Volume
12,960
Avg. Vol
164,710
52-wk High
$83.89
52-wk Low
$53.52

Select another date:

Mon, Feb 12 2018

BRIEF-Emerson And Aspentech To Form Alliance To Deliver Digital Technologies

* EMERSON SAYS CO AND ASPENTECH FORM ALLIANCE TO DELIVER DIGITAL TECHNOLOGIES

BRIEF-Aspentech Acquires Apex Optimisation, Inventors Of Generic Dynamic Optimisation Technology (Gdot)

* ASPENTECH ACQUIRES APEX OPTIMISATION, INVENTORS OF GENERIC DYNAMIC OPTIMISATION TECHNOLOGY (GDOT)

BRIEF-Aspen Technology Q2 Earnings Per Share $0.52

* ASPEN TECHNOLOGY ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER OF FISCAL 2018

BRIEF-Mylan And Aspen Announce Launch Of Generic Busulfex Injection

* MYLAN AND ASPEN ANNOUNCE LAUNCH OF GENERIC BUSULFEX® INJECTION

BRIEF-Aspen Technology Q1 non-GAAP earnings per share $0.53

* Aspen technology announces financial results for the first quarter of fiscal 2018

UK anti-trust regulator investigates South Africa's Aspen Pharmacare

JOHANNESBURG Britain's competition regulator has launched an investigation into Africa's biggest generic drug maker Aspen Pharmacare over alleged anticompetitive conduct in the supply of blood pressure and arthritis drugs, Aspen said on Friday.

UK anti-trust regulator investigates S.Africa's Aspen Pharmacare

JOHANNESBURG, Oct 13 Britain's competition regulator has launched an investigation into Africa's biggest generic drug maker Aspen Pharmacare over alleged anticompetitive conduct in the supply of blood pressure and arthritis drugs, Aspen said on Friday.

South Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

UPDATE 1-S.Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG, Oct 4 South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

S.Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG, Oct 4 South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

Select another date: